Harrow Inc (HROW) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Expansions [Yahoo! Finance]
Harrow, Inc. (HROW)
Last harrow, inc. earnings: 11/13 04:21 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Consolidated Revenue (Q4 2025): $89.1 million, 33% year-over-year growth. Full Year Revenue (2025): $272 million, up 36% versus 2024. Adjusted EBITDA (Q4 2025): $24.2 million. Adjusted EBITDA (Full Year 2025): $61.9 million, 54% year-over-year growth. Cash from Operations (2025): Just under $44 million. Cash and Cash Equivalents (End of 2025): $72.9 million. VEVYE Revenue (Q4 2025): $25.9 million, up 14% sequentially. VEVYE Revenue (Full Year 2025): $88.7 million, 216% increase over 2024. IHEEZO Revenue (Q4 2025): $35.9 million. IHEEZO Revenue (Full Year 2025): $81.3 million, 65% year-over-year growth. TRIESENCE Revenue (Q4 2025): $5.1 million, 36% increase from Q3. TRIESENCE Revenue (Full Year 2025): $9.9 million, 193% increase from 2024. Rare Specialty and Compounding Portfolio Revenue (Q4 2025): $22.2 million. Rare Specialty and Compounding Portfolio Revenue (Full Year 2025): $92.3 million. 2026 Revenue Guidanc
Show less
Read more
Impact Snapshot
Event Time:
HROW
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HROW alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HROW alerts
High impacting Harrow, Inc. news events
Weekly update
A roundup of the hottest topics
HROW
News
- Harrow (HROW) was downgraded by Zacks Research from "hold" to "strong sell".MarketBeat
- Harrow (HROW) had its price target lowered by Cantor Fitzgerald from $94.00 to $91.00. They now have an "overweight" rating on the stock.MarketBeat
- Harrow (HROW) had its price target raised by HC Wainwright from $69.00 to $70.00. They now have a "buy" rating on the stock.MarketBeat
- Harrow to Present at Leerink Partner's 2026 Global Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Harrow to Present at Leerink Partner’s 2026 Global Healthcare ConferenceGlobeNewswire
HROW
Earnings
- 3/2/26 - Miss
HROW
Sec Filings
- 3/11/26 - Form SCHEDULE
- 3/10/26 - Form 8-K
- 3/5/26 - Form 4
- HROW's page on the SEC website